Keynote (green)The impact of COVID-19 on the cell and gene therapies industry: Disruptions, opportunities, and future prospects
Keywords
Cited by (0)
Tingting Qiu is a PhD student at Aix-Marseille University, France, majoring in public health. She has been involved in projects concerning expensive drugs (e.g., orphan drugs and advanced therapies) on the European market since 2017, such as health policy research, value proposition proposal, business model strategy, and expert interviews. She has a MSc in clinical pharmacy from China Pharmaceutical University, and has experience in clinical evidence synthesis and patient education.
Mondher Toumi has an MD and MSc in biostatistics and in biological sciences (option pharmacology) and a PhD in economic sciences. He is professor of public health at Aix-Marseille University, France. He is also the founder of Creativ-Ceutical, an international consulting firm dedicated to supporting health industries and authorities in strategic decision-making. He also created the European Market Access University Diploma (EMAUD). He is a recognised expert in health economics and an authority on drugs market access and risk management.